Clinical Trial Update: A Study of Adavosertib as Treatment for Uterine Serous Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating adavosertib for uterine serous carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Serous Carcinoma

Drugs mentioned

• Adavosertib (adavosertib)

Snippet

Sponsor: AstraZeneca | Conditions: Uterine Serous Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-08-14